![Sapna R. Srivastava](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 370 257 $ al 31/07/2026
Sapna R.
Srivastava is an Independent Director at SQZ Biotechnologies Co. since 2020, Independent Non-Executive Director at Aura Biosciences, Inc. since 2021, Director at AsclepiX Therapeutics LLC since 2019, Director at Trickle Up Program, Inc. since 2013, Independent Director at Alumis, Inc. since 2022, and Strategic Advisor at BioPlus Acquisition Corp.
Former roles include Independent Director at MYOS RENS Technology, Inc. from 2014 to 2016, Director at VelosBio, Inc. in 2020, Independent Director at Innoviva, Inc. from 2023 to 2025, Independent Director at Social Capital Suvretta Holdings Corp.
II from 2021 to 2023, Independent Director at Talaris Therapeutics, Inc. from 2021 to 2023, Independent Director at Tourmaline Bio, Inc. from 2023 to 2025, Independent Director at Nuvalent, Inc. from 2021 to 2026, Chief Financial & Strategy Officer at Abide Therapeutics, Inc. from 2017 to 2019, Research Analyst at Morgan Stanley & Co. LLC, Analyst at Goldman Sachs & Co. LLC in 2010, Analyst at Thomas Weisel Partners LLC in 2010, Chief Financial & Strategy Officer at Intellia Therapeutics, Inc. from 2015 to 2016, Chief Financial Officer at eGenesis, Inc. in 2021, and Associate at JP Morgan Direct Corporate Finance.
Education includes a doctorate from New York University School of Medicine and an undergraduate degree from St. Xavier's College (Mumbai).
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,04 % | 11/06/2026 | 38.500 ( 0,04 % ) | 269 885 $ | 31/07/2026 |
ALUMIS INC. 0 % | 30/06/2026 | 3.553 ( 0 % ) | 100 372 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Director/Miembro de la Junta | 23/10/2020 |
| AURA BIOSCIENCES, INC. | Director/Miembro de la Junta | 01/05/2021 |
| BIOPLUS ACQUISITION CORP. | Corporate Officer/Principal | - |
| ALUMIS INC. | Director/Miembro de la Junta | 01/05/2022 |
AsclepiX Therapeutics LLC
 AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drug technology | Director/Miembro de la Junta | 01/12/2019 |
Trickle Up Program, Inc.
 Trickle Up Program, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which provides poverty and vulnerability services | Director/Miembro de la Junta | 01/01/2013 |
| Empresas | Cargo | Fin |
|---|---|---|
| NUVALENT, INC. | Director/Miembro de la Junta | 15/07/2026 |
| INNOVIVA, INC. | Director/Miembro de la Junta | 19/05/2025 |
| TOUE BIOPAR | Director/Miembro de la Junta | 26/10/2023 |
| ░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 21 |
|---|---|
MYOS RENS Technology, Inc.
 MYOS RENS Technology, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes therapeutic products, nutritional supplements and other technologies | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | Health Technology |
SQZ Biotechnologies Co.
 SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Thomas Weisel Partners LLC
 Thomas Weisel Partners LLC Regional BanksFinance Operates as an investment banking firm | Finance |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Trickle Up Program, Inc.
Trickle Up Program, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which provides poverty and vulnerability services | Commercial Services |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
St. Xavier's College (Mumbai)
 St. Xavier's College (Mumbai) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
eGenesis, Inc.
 eGenesis, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology company that provides organs and cells transplantation services | Health Services |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drug technology | Commercial Services |
VelosBio, Inc.
 VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research activities | Commercial Services |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
Social Capital Suvretta Holdings Corp. II
 Social Capital Suvretta Holdings Corp. II Financial ConglomeratesFinance Operates as blank check company | Finance |
BioPlus Acquisition Corp.
 BioPlus Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Jp Morgan Direct Corporate Finance
 Jp Morgan Direct Corporate Finance Investment ManagersFinance Functions as a private equity fund | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
